NASDAQ Markets
· Jul 21, 2025 5:33 AM EDT
Not market news
Roche Announces Mixed Results For Astegolimab In COPD Trials
(RTTNews) - Roche (RHHBY) announced results from two clinical trials evaluating astegolimab in people with moderate to very severe chronic obstructive pulmonary disease or COPD, alongside standard maintenance therapy.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
